Subscribe
natrot-shutterstock-com-
natrot / Shutterstock.com
20 April 2020AmericasSarah Morgan

Fed Circuit resuscitates heart monitoring patent

The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company  BioTelemetry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
SCOTUS won’t resuscitate heart monitor patent case
26 January 2021   In a win for medical laboratory BioTelemetry, the US Supreme Court has refused to review a court ruling that revived a cardiac monitoring patent.
Americas
Fed Circ grants Arthrex remand, rejects Iancu conflict
10 September 2020   The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.
Americas
Federal Circuit remands Abbott drug test patent suit
14 April 2020   The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

More on this story

Americas
SCOTUS won’t resuscitate heart monitor patent case
26 January 2021   In a win for medical laboratory BioTelemetry, the US Supreme Court has refused to review a court ruling that revived a cardiac monitoring patent.
Americas
Fed Circ grants Arthrex remand, rejects Iancu conflict
10 September 2020   The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.
Americas
Federal Circuit remands Abbott drug test patent suit
14 April 2020   The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics.

More on this story

Americas
SCOTUS won’t resuscitate heart monitor patent case
26 January 2021   In a win for medical laboratory BioTelemetry, the US Supreme Court has refused to review a court ruling that revived a cardiac monitoring patent.
Americas
Fed Circ grants Arthrex remand, rejects Iancu conflict
10 September 2020   The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.
Americas
Federal Circuit remands Abbott drug test patent suit
14 April 2020   The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?